FDA Inspection 1081937 — Donna Hogge, M.D.
The FDA completed an inspection of Donna Hogge, M.D. on Feb 1, 2019 in Vancouver. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 1, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Vancouver (Canada)
Additional Details
Clinical Investigator (CI)